Heuking advises Stille AB, a company listed on the Swedish stock exchange, by entering into an agreement to acquire Fehling Instruments
A Heuking-team led by Kristina Schneider, Partner at Heuking Kühn Lüer Wojtek’s Cologne office and Dr. Katharina Prasuhn, Partner at Heuking Kühn Lüer Wojtek’s Munich office has advised Stille AB (publ) (“Stille” or the “Company”), a company listed on the Swedish stock exchange, by entering into an agreement to acquire all shares outstanding of Fehling Instruments GmbH & Co. KG and Fehling Verwaltungs GmbH (jointly “Fehling”) involving eight jurisdictions. The acquisition is conditional upon the Company receiving sufficient financing to carry out the acquisition and the Company's board of directors thus intends to resolve on a directed issue of shares subject to the general meeting's subsequent approval. Through the acquisition, Stille significantly broadens its product offering, global footprint and R&D capabilities.
Background and acquisition of Fehling
Long history of manufacturing premium surgical instruments
Fehling is a family-owned German company, founded in 1996, that develops and sells high-quality medical instruments. Fehling has a strong market position with direct operations in Germany, Switzerland, USA, Singapore, UAE, and Malaysia. With over 30 years of industry experience, Fehling strives to provide a broad range of premium products to surgeons, with focus on demanding specialties such as open and minimally invasive cardiac, thoracic, neuro-, and spine surgery. Fehling boasts a global sales footprint combined by direct sales and distributors. The sales growth in 2022 amounted to 9 percent with a mix of sales divided between traditional instruments amounting to approximately 72 percent, micro instruments amounting to approximately 18 percent and MICS amounting to approximately 10 percent.1
About Stille AB (publ)
Stille AB (publ) develops, manufactures and markets medical devices for surgeons across the world. Stille was founded in 1841 and is one of the world’s oldest medical device companies. Stille’s main business areas are surgical instruments and c-arm tables. Stille’s surgical instruments are mostly used during different kinds of open surgery. During minimal invasive procedures. the c-arm tables imagiQ2 and Medstone are key products. The company has a strong brand and products of a renowned high-quality. The share is listed on First North Growth Market under the acronym “STIL”.
Stille AB’s Advisors
Heuking Kühn Lüer Wojtek:
Kristina Schneider, LL.M. (Lead), Cologne,
Dr. Katharina Prasuhn (Lead, coordination foreign counsel), Munich,
Dr. Ann-Kathrin Jungen,
Meike Daniels,
Michael Kömpel (all M&A),
Dr. Lutz Martin Keppeler,
Markus Lennartz,
Manuel Poncza,
Dr. Ruben Schneider (all IT),
Dr. Christoph Schork, LL.M. (ESG), all Cologne,
Dr. Henrik Lay (Tax),
Tim Petermann (Commercial Law), both Hamburg,
Catarina Angelika Seemann, LL.M.,
Kim Anna Schwick (both Health Care & Life Sciences), all Munich,
Dr. Alexander Bork (Employment),
Mathis Dick, LL.M. (Real Estate),
Marcel Maybaum,
Astrid Luedtke (both IP),
Beatrice Stange, LL.M. (Antitrust law ), all Düsseldorf,
Wolfram Meven,
Michael Kreisler, LL.M. (both Foreign Trade Law), all Düsseldorf.
Foreign Legal Advisors:
Stephenson Harwood (UAE and Singapore)
Kilpatrick Townsend & Stockton LLP (USA)
Shearn Delamore & Co. (Malaysia)
Kellerhals Carrard (Schweiz)
SSW Pragmatic Solutions Spaczyński, Szczepaniak, Okoń sp.k. (Poland)
